Correlation Between Immunoprecise Antibodies and Intel Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immunoprecise Antibodies and Intel Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunoprecise Antibodies and Intel Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunoprecise Antibodies and Intel Corp, you can compare the effects of market volatilities on Immunoprecise Antibodies and Intel Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunoprecise Antibodies with a short position of Intel Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunoprecise Antibodies and Intel Corp.

Diversification Opportunities for Immunoprecise Antibodies and Intel Corp

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Immunoprecise and Intel is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Immunoprecise Antibodies and Intel Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intel Corp and Immunoprecise Antibodies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunoprecise Antibodies are associated (or correlated) with Intel Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intel Corp has no effect on the direction of Immunoprecise Antibodies i.e., Immunoprecise Antibodies and Intel Corp go up and down completely randomly.

Pair Corralation between Immunoprecise Antibodies and Intel Corp

Considering the 90-day investment horizon Immunoprecise Antibodies is expected to generate 3.89 times more return on investment than Intel Corp. However, Immunoprecise Antibodies is 3.89 times more volatile than Intel Corp. It trades about 0.01 of its potential returns per unit of risk. Intel Corp is currently generating about -0.05 per unit of risk. If you would invest  1,018  in Immunoprecise Antibodies on July 1, 2022 and sell it today you would lose (629.00)  from holding Immunoprecise Antibodies or give up 61.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Immunoprecise Antibodies  vs.  Intel Corp

 Performance (%) 
       Timeline  
Immunoprecise Antibodies 
Immunoprecise Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Immunoprecise Antibodies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Immunoprecise Antibodies may actually be approaching a critical reversion point that can send shares even higher in October 2022.

Immunoprecise Price Channel

Intel Corp 
Intel Performance
0 of 100
Over the last 90 days Intel Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Intel Price Channel

Immunoprecise Antibodies and Intel Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immunoprecise Antibodies and Intel Corp

The main advantage of trading using opposite Immunoprecise Antibodies and Intel Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunoprecise Antibodies position performs unexpectedly, Intel Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intel Corp will offset losses from the drop in Intel Corp's long position.
Immunoprecise Antibodies vs. Morningstar
Immunoprecise Antibodies vs. Singapore Exchan
Immunoprecise Antibodies vs. Singapore Exchange L
Immunoprecise Antibodies vs. JAPAN EXCHANGE GROUP
The idea behind Immunoprecise Antibodies and Intel Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Intel Corp vs. Amazon Inc
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go